CIGA Healthcare is a British manufacturer of lateral flow assay diagnostic tests.[1] It is under contract to the British government for the supply of AbC-19 rapid antibody tests,[2] a test for the presence of IgG antibody against the SARS-CoV-2 spike protein,[3] as part of the UK Rapid Test Consortium program.[4]
CIGA Healthcare will be responsible[when?] for assembly and distribution of the AbC-19 rapid antibody tests, and has also been awarded distribution in the US after recent FDA approval.[5]